Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an interview on Saturday, with the pharmaceuticals giant having nothing to fear ...

Ad hoc announcement pursuant to Art. 53 LR André C. Muller, current CEO of Idorsia, to retire and act as an advisor to the company to ensure a smooth transition Allschwil, Switzerland – June 10, ...

Novartis CEO Vas Narasimhan joins Yahoo Finance Live to discuss company earnings, focusing efforts on fighting cancer, consumer health, and cutting roughly 10% of the global healthcare company’s ...

Novartis (NYSE:NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of tariffs this year. During a CNBC interview, Narasimhan emphasized the ...

Some information may no longer be current. CEO Vas Narasimhan of Swiss drugmaker Novartis addresses the company's annual news conference in Basel, Switzerland, Jan. 30, 2019. Arnd Wiegmann/Reuters ...